News Headlines Article

FDA targets unapproved drugs containing oxycodone
Modern Healthcare

Companies that manufacture and distribute certain unapproved drugs containing the pain reliever oxycodone will have 45 days to stop making those products and 90 days to stop shipping them, the U.S. Food and Drug Administration announced Thursday.

The FDA’s notice in the Federal Register said the agency would take enforcement action against all unapproved, single-ingredient, immediate-release products containing oxycodone that are taken orally—including tablets, capsules and oral solutions—and are labeled for human use.